Liver Fluke Induces Cholangiocarcinoma

Picture a village in northeast Thailand, early evening, the Chi River just audible somewhere beyond the tree line. A communal meal is being prepared — koi-pla, a dish made from raw cyprinoid fish caught that morning, pounded with herbs, spices, and lime, and passed around in a shared bowl. It looks a little like ceviche. It tastes like home. And inside nearly every bite, invisible to everyone at the table, are the encysted larvae of a flatworm called Opisthorchis viverrini. Not dangerous in the way venom is dangerous, or cholera is dangerous. Dangerous the way a slow fire is dangerous — undetected for years, sometimes decades, until the damage is already done. That damage is cholangiocarcinoma: cancer of the bile ducts. Sripa and colleagues have spent their careers working out exactly how a small flatworm turns a meal into a malignancy. The lifecycle of Opisthorchis viverrini is a feat of biological patience. Eggs pass out of an infected human in stool, reach fresh water, and are eaten by aquatic snails of the genus Bithynia. Inside the snail, each egg hatches and develops through several larval stages before the snail releases free-swimming cercariae. Those cercariae find a fish — species like Cyclocheilichthys armatus or Puntius leiacanthus, both common in regional rivers — and burrow in, encysting in the fins, skin, and muscle as metacercariae. When a person eats that fish raw, as in koi-pla, the metacercaria excysts in the duodenum, migrates up the biliary tract through the ampulla of Vater, and settles into the small and medium bile ducts as an adult worm roughly 10 to 25 millimeters long. Maturation takes about one month. After that, the fluke can persist for decades. The scale of this problem is hard to overstate. More than 600 million people across East Asia and Eastern Europe are at risk. In Thailand alone, an estimated 6 million people were infected as of 2001, a national prevalence of about 9.4 percent. But that average conceals dramatic regional clustering: prevalence reaches 19.3 percent in the north, 15.7 percent in the northeast, and in some endemic localities approaches 70 percent, even after mass treatment campaigns with praziquantel. Most infected people have no symptoms — just a mild ache, some flatulence, or fatigue at worst. That silence is part of what makes the infection so dangerous. The geographic distribution of infection produced a geographic distribution of cancer so stark it was almost impossible to ignore. Sripa and colleagues report that cholangiocarcinoma accounts for about 19 percent of liver cancers in the United States. In Khon Kaen province in northeast Thailand — the heart of Opisthorchis viverrini's range — it accounts for 71 percent. Khon Kaen has the highest incidence of bile-duct cancer in the world. Across Thailand's major regions, cholangiocarcinoma incidence varies by at least twelvefold, and that variation tracks almost exactly with fluke prevalence as measured by anti-Opisthorchis viverrini antibody levels in the population. The odds ratio linking elevated egg counts to suspected cholangiocarcinoma was 14.1. Elevated antibody levels pushed the risk estimate as high as 27-fold. These are large numbers, and they told researchers there was a causal story here, not just a coincidence of geography. Cholangiocarcinoma, for listeners unfamiliar with it, is cancer arising from the epithelial cells lining the bile ducts — cells called cholangiocytes. It is formidably difficult to detect early, rarely operable, and in most cases treatable only by complete liver transplantation. The epidemiology pointed to a cause. The harder question was the mechanism. Sripa and colleagues describe two intertwined pathways by which the fluke drives malignant transformation. The first is direct mechanical damage. Adult flukes use oral and ventral suckers to attach to and graze the bile-duct lining, producing ulceration. Eggs passing through those ulcerated sites become trapped in surrounding tissue and trigger granulomatous inflammation. Compounding the physical damage, the fluke releases excretory and secretory products into bile that are biologically active. When mouse fibroblasts were cultured with adult Opisthorchis viverrini — separated by a membrane so only molecules, not the worm itself, could cross — they proliferated at more than four times the rate of control cells. Gene expression studies of those fibroblasts showed upregulation of growth-promoting proteins including transforming growth factor. Human cholangiocarcinoma cell lines responded similarly when exposed to soluble fluke secretions. The parasite is not just an irritant. It is actively pushing cells to divide. The second pathway is immunological. The host immune system responds to the infection by flooding bile-duct tissue with macrophages, epithelioid cells, and giant cells. Those activated immune cells produce reactive oxygen and nitrogen species — including nitric oxide synthesized by an enzyme called inducible nitric oxide synthase. Reactive nitrogen species are not selective weapons. They damage the tissue they're meant to protect. In hamsters infected with Opisthorchis viverrini, Sripa and colleagues detected diffuse nitrative and oxidative DNA damage in biliary epithelium that persisted for at least 180 days post-infection. Repeated infections worsened the damage, corresponding with increased expression of inducible nitric oxide synthase in bile-duct cells. When the infection was cleared with praziquantel, the DNA lesions disappeared — confirming they were driven by the inflammatory response to the parasite, not by some independent process. The specific molecular injuries are worth naming precisely, because they are the link between inflammation and mutation. The first is 8-nitroguanine, a nitrative lesion in which a nitro group is attached to guanine, one of the four bases in DNA. The second is 8-oxo-7,8-dihydro-2'-deoxyguanosine — abbreviated 8-oxodG — in which an oxygen atom modifies the same base through an oxidative reaction. Both modifications cause guanine to be misread during DNA replication, inserting the wrong base in the new strand and thereby fixing a mutation. The paper describes 8-oxodG explicitly as mutagenic. Nitric oxide compounds the problem further by inhibiting DNA repair mechanisms and interfering with apoptosis — the cell-death process that normally eliminates damaged cells before they can proliferate. A biliary cell that carries a mutated guanine, cannot repair it, and does not die is precisely the kind of cell that starts a tumor. Then the story deepens. The fluke and the inflammatory chemistry it triggers are not operating alone. Sripa and colleagues show that the regional diet adds a third carcinogenic layer through nitrosamines. Fermented and preserved fish dishes — particularly pla-ra, a preserved mudfish paste ubiquitous in northeastern Thailand and Laos — contain N-nitroso compounds and their precursors at low levels. The critical experimental evidence: cholangiocarcinoma can be reliably induced in hamsters that are both infected with Opisthorchis viverrini and exposed to sub-carcinogenic doses of nitrosamine. Hamsters with infection alone, without the nitrosamine exposure, do not develop cholangiocarcinoma. Neither does nitrosamine alone at those doses. It takes both. The body also produces its own nitrosamines. Sripa and colleagues show that Opisthorchis viverrini infection in hamsters increases endogenous nitrosation — the internal formation of carcinogenic nitrosamines — by upregulating nitric oxide synthase in immune cells. This isn't just a laboratory finding: infected people have a measurably higher endogenous nitrosation potential than uninfected controls. Plasma and urinary nitrate and nitrite were elevated in infected men, as were markers of nitrosation of compounds like proline and thioproline. Praziquantel treatment normalized those levels. So did co-administration of ascorbic acid with proline, pointing toward an accessible dietary intervention. It is not just the worm. It is the worm plus what people eat and what their own inflamed tissues produce, compounding the carcinogenic signal from multiple directions at once. What can actually be done? The simplest answer is also the most direct: cook the fish. Thorough cooking destroys metacercariae. Praziquantel clears existing infection and reverses some measurable damage — ultrasound-detected gallbladder enlargement resolves after treatment, and both endogenous nitrosation and DNA lesions disappear. But reinfection is common in communities where koi-pla is a cultural cornerstone, not just a meal. Control is genuinely hard. The parasite cycles through rivers, snails, fish farming ponds contaminated by untreated sewage, and animal reservoir hosts — a system that will not be dismantled by treating people alone. For longer-term gains, Sripa and colleagues argue for two research fronts: first, developing sensitive biomarker assays — detecting oxidative damage markers in serum, urine, or feces — to screen at-risk populations for early cancer before symptoms appear; and second, deepening understanding of the inflammation-to-cancer pipeline well enough to interrupt it. Antioxidant interventions, given the ascorbic acid data, may offer one practical handle. The conclusion that grounds all of it is this: liver-fluke-associated cholangiocarcinoma is, in principle, preventable. That is not a consolation. It is an indictment of how slowly a cancer can be recognized and how long the people most at risk can wait for the rest of the world to notice. This lecture was created by ennepō. Go to https://ennepo.ai to Discover, Create and Follow the latest research in your field. Read when you can. Listen when you want to.